H. Frederick Bowman, Ph.D., President, CEO & Chairman

Dr. Bowman is the inventor of the Company’s technology and the founder of Hemedex. He is also the founder of Thermal Technologies, Inc. and serves as Chairman and Chief Technology Officer. He concurrently served as the Senior Academic Administrator of the Harvard-MIT Division of Health Sciences and Technology for 40 years through September 2010. He served as a member of the Mechanical and Biomedical Engineering faculties at Northeastern University for 25 years, as a lecturer on Radiation Oncology at Harvard Medical School, and as Program Director for Biomedical Engineering at the National Science Foundation. His principal research interests include microprocessor-based instrumentation for the quantification of tissue perfusion, thermal properties, tissue water content, cardiac output, bioheat and mass transfer based problems in clinical research, thermal physics of clinical hyperthermia, and thermometry. Dr. Bowman has a B.S. degree in Mechanical Engineering from Pennsylvania State University and M.S. and Ph.D. degrees from MIT in Nuclear Engineering. He is the author of some 120 publications and abstracts, holds 20 patents and is a Fellow of the American Institute of Medical and Biological Engineers.

Scott D. Greenwald, Ph.D., Vice President of Technology

Dr. Greenwald joined Hemedex, Inc. in 2012 bringing 20 years of experience managing innovative, early-phase development of novel medical devices, most notably the Bispectral Index (BIS) developed by Aspect Medical Systems. Dr. Greenwald has expertise in biomedical signal processing, analytics and outcomes research, and is a significant individual contributor as co-inventor of 3 novel patient monitoring technologies (BIS, CVI, and ATR), co-author of 8 US Patents, and co-author of 100+ publications that support the development, clinical utility, and benefits of the technologies he helped to develop. Prior to joining Hemedex, he served Covidien (3yrs) as Sr. Director of Advanced Research for the Respiratory and Patient Monitoring business unit. Previously, he worked with Aspect Medical Systems (17 yrs.), serving most recently as Vice President of Research. Dr. Greenwald received a B.S. in Engineering jointly from the departments of Biomedical and Electrical Engineering from Duke University, a S.M. in Electrical Engineering and Computer Science from MIT, and a Ph.D. in Medical Engineering from MIT via the Harvard-MIT Division of Health Sciences and Technology.

James L. Neal, J.D., Chief Legal Counsel

Mr. Neal is an experienced attorney in corporate, commercial and patent law. He has 15 years of experience serving as Chief Legal Counsel for a major technology company and 8 years of experience in private practice. He has also served as Patent Counsel for several US companies. Mr. Neal is a co-founder of Hemedex where he oversees the development of intellectual property and legal affairs. Prior to Hemedex, he served as Corporate Counsel at Thermo Electron Corporation, a multinational provider of products and services in the energy, environmental and biomedical fields. He was also formerly a patent attorney at Westvaco and Polaroid Corporations. Mr. Neal has a B.S. degree in Civil Engineering from North Carolina State University and a Juris Doctorate (Law) from American University in Washington, D.C.


Tracey M. Berlin MSN-Ed, RN, CNRN, CCRN; Consultant, Clinical Applications Specialist

Ms. Berlin has 29 years of experience in neuroscience nursing, serving in roles of staff nurse, management, education, and research. Prior to joining the Hemedex team, she was employed as the Unit Educator and Neuroscience Technology Specialist in a 24 bed Neuro ICU in a University-based Level I Trauma Center/Primary Stroke Center. Ms. Berlin currently works as a Neuroscience Nursing Education Consultant and Clinical Applications Specialist for several companies focusing on advanced neuromonitoring technologies. She is considered a nursing expert on multimodal monitoring in neurocritical care, teaching on topics of brain tissue oxygen monitoring, cerebral blood flow monitoring, cerebral microdialysis, automated pupil assessment, data integration systems, and others. She has authored textbook chapters and publications on these and other neuro related topics. Her clinical experience and unique skill set enable her to assist hospitals with expansion of neurocritical care programs and integration of neuromonitoring technologies.

« Previous pageNext page »